684
Participants
Start Date
March 15, 2018
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
Measurement of MR-proADM
It is an observational study. The only intervention was the measure of MR-proADM, but no clinical decision was made based on its value, since the physician attending the patient did´n know the value of MR-proADM
Hospita Clínico San Carlos, Madrid
Hospital Universitario General de Alicante, Alicante
Hospital Universitario de Bellvitge, Barcelona
Thermo Fisher Scientific, Inc
INDUSTRY
Juan González-del Castillo
OTHER